Skip to main content
Caplight Logo









TwoStep Therapeutics

TwoStep Therapeutics

Private
San Carlos, CaliforniaHealthcare & Life Scienceshttps://twosteptx.com

Last Round

Series A

Sep 9, 2026

Est. Valuation

$64.5M

Total Funding Raised

$92.3M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

TwoStep Therapeutics operates in Healthcare & Life Sciences and is based in San Carlos, California. Its latest recorded funding round was a Series A round in September 2026.

TwoStep Therapeutics is a biotechnology company developing a pipeline of targeted cancer therapies for solid tumors using a unique polyspecific integrin-binding peptide (PIP) that selectively binds to multiple targets highly expressed on solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

TwoStep Therapeutics Comparables

Compare TwoStep Therapeutics with similar companies based on industry and business-model similarity.

TwoStep Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Actithera
88%
ARTBIO
88%
Ariceum Therapeutics
88%
Book a demo to see all comparables

For institutional investors. Book with your work email.

TwoStep Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 9, 2026
Series AJan 20, 2026
SeedMar 19, 2025
SeedJun 25, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Caitlyn Miller

Co-Founder CEO, Co-Founder

Founding Team

For institutional investors. Book with your work email.

TwoStep Therapeutics Investors

Notable investors and investment history

TwoStep Therapeutics investors
InvestorRounds
NFXSeries A, Seed
M VenturesSeries A
Medical Excellence CapitalSeries A
Alexandria Venture InvestmentsSeed
2048 VenturesSeed, Series A
CooleySeed
Pfizer VenturesSeries A
Book a demo to see all 8 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 9, 2026

    $63M round with participation from M Ventures and Pfizer Ventures.

  • Jun 30, 2026

    Grew 38% QoQ from 8 to 11 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • receives_financingSep 9, 2026

    Twosteptx receives an oversubscribed $62.5M Series A led by Insight Partners and Medical Excellence Capital, with M Ventures and Pfizer Ventures joining as co-lead investors, to advance TS-104 into Phase 1 in California on Sep 9th '26.

Book a demo to see all news

For institutional investors. Book with your work email.

TwoStep Therapeutics Filings

Explore SEC and related filing metadata, where available.

TwoStep Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about TwoStep Therapeutics's valuation, stock price, and market status.

Is TwoStep Therapeutics a public or private company?

TwoStep Therapeutics is a private company.

What is the current stock price of TwoStep Therapeutics?

TwoStep Therapeutics is a private company, so its shares have no public market price. Caplight tracks TwoStep Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is TwoStep Therapeutics worth (valuation)?

TwoStep Therapeutics's valuation is estimated at $64.5M based on funding round data.

Can I buy TwoStep Therapeutics stock?

TwoStep Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was TwoStep Therapeutics's last funding round?

TwoStep Therapeutics's most recent funding round was Series A on September 9, 2026.

Who are the main investors in TwoStep Therapeutics?

Key investors in TwoStep Therapeutics include NFX.

Will TwoStep Therapeutics IPO soon?

No public IPO plans have been announced for TwoStep Therapeutics.

How can I track TwoStep Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades in TwoStep Therapeutics's shares on secondary markets.

Firmographic Details

HeadquartersSan Carlos, California
Employee Range8
Year Founded2023
Last FundingSep 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?